Citation Impact
Citing Papers
Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Prospective Randomized Trial
2012
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Rodent-borne diseases and their risks for public health
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma
2008
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
2005
Prevalence of hepatitis E virus in swine under different breeding environment and abattoir in Beijing, China
2008
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Radiofrequency Ablation of Liver Cancer
2007
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Radiofrequency Thermal Ablation vs. Percutaneous Ethanol Injection for Small Hepatocellular Carcinoma in Cirrhosis: Meta-Analysis of Randomized Controlled Trials
2009
Frequency of and Predictive Factors for Vascular Invasion after Radiofrequency Ablation for Hepatocellular Carcinoma
2014
Microwave coagulation therapy for hepatic tumors: Review of the literature and critical analysis
2009
Hepatocellular Cancer: A Guide for the Internist
2007
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer
2009
Percutaneous treatment of hepatocellular carcinoma: State of the art and innovations
2017
Hepatocellular carcinoma
2012 Standout
Image-Guided Ablation for Hepatocellular Carcinoma
2012
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Cross‐species infection of specific‐pathogen‐free pigs by a genotype 4 strain of human hepatitis E virus
2008
Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient
2005
Image-guided ablation of primary liver and renal tumours
2015
Hepatic resection versus radiofrequency ablation for very early stage hepatocellular carcinoma
2009
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Validation of the HCC‐MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy
2008
Management of Hepatocellular Carcinoma *
2005 Standout
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Quality Improvement Guidelines for Radiofrequency Ablation of Liver Tumours
2009
Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study
2016
Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)
2008
Portal hypertensive bleeding in cirrhosis
2016 Standout
Prevalence of hepatitis E virus among wild boar in the Ehime area of western Japan
2007
Are Patients with Child’s A Cirrhosis and Hepatocellular Carcinoma Appropriate Candidates for Liver Transplantation?
2011
Changing Paradigm in the Management of Hepatocellular Carcinoma Improves the Survival Benefit of Early Detection by Screening
2008
Food-borne diseases — The challenges of 20 years ago still persist while new ones continue to emerge
2010 Standout
Chronic hepatitis B
2007 Standout
Swine Hepatitis E Virus: Cross-Species
2003
Chronic hepatitis B: Update 2009 #
2009 Standout
Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma
2016
Loco‐regional treatment of hepatocellular carcinoma†
2010
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
2014 Standout
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
2010 Standout
Diagnosis and Treatment of Hepatocellular Carcinoma
2008
Hepatitis E is an autochthonous disease in industrialized countries
2006
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysis
2010
Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
2008 Standout
A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma
2005
Local-Regional Treatment of Hepatocellular Carcinoma
2011
The detection and characterization of hepatitis E virus in pig livers from retail markets of India
2008
Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
2011
PIVKA-II Is the Best Prognostic Predictor in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation Therapy
2008
Liposomes as nanomedical devices
2015 Standout
Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies #
2008
Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series
2006
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
2009 Standout
Isolation, detection and characterization of swine hepatitis E virus from herds in Costa Rica
2008
Hepatocellular Carcinoma
2011 Standout
<p>Image-Guided Percutaneous Microwave Ablation Versus Cryoablation For Hepatocellular Carcinoma In High-Risk Locations: Intermediate-Term Results</p>
2019
Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
2010 Standout
Hepatocellular carcinoma
2022 Standout
Liver histology in patients with sporadic acute hepatitis E: a study of 11 patients from South-West France
2007
Hepatocellular carcinoma: a global view
2010
Hepatitis E viruses in humans and animals
2004
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be food-borne, as suggested by the presence of hepatitis E virus in pig liver as food
2003
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Wild boars as sources for infectious diseases in livestock and humans
2009 Standout
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Percutaneous Ablation for Hepatocellular Carcinoma: Comparison of Various Ablation Techniques and Surgery
2018
Splicing Diversity of the Human OCLN Gene and Its Biological Significance for Hepatitis C Virus Entry
2010 StandoutNobel
Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma
2013
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma
2011
Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control study
2013
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Identification of Novel Human Hepatitis E Virus (HEV) Isolates and Determination of the Seroprevalence of HEV in Korea
2005
Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: A randomized trial
2014
Effectiveness, Safety, and Local Progression After Percutaneous Laser Ablation for Hepatocellular Carcinoma Nodules up to 4 cm Are Not Affected by Tumor Location
2012
Hepatitis E Virus Infection among Domestic Animals in Eastern China
2008
Management of people with early- or very early-stage hepatocellular carcinoma
2017
Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma
2014
Works of Chen‐Chun Lin being referenced
Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan
2002
Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma ≤4 cm
2004
Spread of hepatitis E virus among different‐aged pigs: two‐year survey in Taiwan
2002
Radiofrequency ablation following artificial ascites and pleural effusion creation may improve outcomes for hepatocellular carcinoma in high-risk locations
2018
The Effectiveness of Multiple Electrode Radiofrequency Ablation in Patients with Hepatocellular Carcinoma with Lesions More than 3 cm in Size and Barcelona Clinic Liver Cancer Stage A to B2
2015
Diagnostic Value of Immunoglobulin G (IgG) and IgM Anti-Hepatitis E Virus (HEV) Tests Based on HEV RNA in an Area Where Hepatitis E Is Not Endemic
2000
Combined Percutaneous Radiofrequency Ablation and Ethanol Injection for Hepatocellular Carcinoma in High-Risk Locations
2008